Financial results - TONIDEMA MED SRL

Financial Summary - Tonidema Med Srl
Unique identification code: 35954455
Registration number: J09/247/2016
Nace: 8622
Sales - Ron
64.479
Net Profit - Ron
27.728
Employee
1
The most important financial indicators for the company Tonidema Med Srl - Unique Identification Number 35954455: sales in 2023 was 64.479 euro, registering a net profit of 27.728 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
Sales - Ron10K44K76K98K86K135K163K64K2016201620172017201820182019201920202020202120212022202220232023

Sales, Profit, Employees, Debts, Capitals, Financial Results - Tonidema Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 10.228 43.857 75.804 97.516 86.264 135.144 162.667 64.479
Total Income - EUR - - 10.228 43.857 75.804 97.516 86.264 135.144 162.667 64.609
Total Expenses - EUR - - 53 2.640 18.455 11.118 7.661 16.501 16.109 36.248
Gross Profit/Loss - EUR - - 10.175 41.217 57.349 86.398 78.602 118.643 146.558 28.361
Net Profit/Loss - EUR - - 9.868 39.901 55.074 83.472 76.203 114.589 142.520 27.728
Employees - - 0 0 0 0 0 0 0 1
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales decreased by -60.2%, from 162.667 euro in the year 2022, to 64.479 euro in 2023. The Net Profit decreased by -114.360 euro, from 142.520 euro in 2022, to 27.728 in the last year.
Sales - Ron10K44K76K98K86K135K163K64K2016201620172017201820182019201920202020202120212022202220232023
Net Profit - Ron9.9K40K55K83K76K115K143K28K2016201620172017201820182019201920202020202120212022202220232023
Employees000000012016201620172017201820182019201920202020202120212022202220232023

Check the financial reports for the company - Tonidema Med Srl

Rating financiar

Financial Rating -
Tonidema Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Tonidema Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Tonidema Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Tonidema Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Tonidema Med Srl - CUI 35954455

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 65.779 99.006 97.129 110.491 112.108 64.484
Current Assets - - 10.022 49.999 58.344 102.854 141.549 203.907 242.132 152.953
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 410 910 0 0 0 0 7.872
Cash - - 10.022 49.589 57.434 102.854 141.549 203.907 242.132 145.081
Shareholders Funds - - 9.912 49.646 103.809 185.271 226.407 306.177 348.257 215.979
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 110 353 20.314 16.590 12.272 8.221 5.983 1.459
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 152.953 euro in 2023 which includes Inventories of 0 euro, Receivables of 7.872 euro and cash availability of 145.081 euro.
The company's Equity was valued at 215.979 euro, while total Liabilities amounted to 1.459 euro. Equity decreased by -131.223 euro, from 348.257 euro in 2022, to 215.979 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Tonidema Med Srl

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Tonidema Med Srl

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.